Vildiabate M 500 Tablet 15

Vildiabate M 500 Tablet 15 may interact with the following medications, including

• Cationic Medications: Metformin, a key component of Vildiabate M 500 Tablet 15, can interact with cationic medications like amiloride, digoxin, and trimethoprim, potentially increasing their plasma concentrations.
• Iodinated Contrast Agents: Using these agents with Vildiabate M 500 Tablet 15 may lead to acute kidney failure and lactic acidosis. It’s advisable to temporarily discontinue the medication during such procedures.
• CYP3A4 Inducers: Medicines like rifampicin may reduce the effectiveness of vildagliptin, another active ingredient in Vildiabate M 500 Tablet 15.

Vildiabate M 500 Tablet 15 can interact with conditions/diseases, including

• Kidney Impairment: Not recommended for individuals with kidney disease as metformin is primarily excreted through the kidneys.
• Diabetic Ketoacidosis: Unsuitable for patients with this condition.
• Severe Liver Dysfunction: Should be avoided in severe liver disease as it may worsen the condition.

The daily dose of Vildiabate M 500 Tablet 15 is taken as the doctor prescribes. Your doctor will decide the dosage and timing based on age, severity of the condition and overall health. 

The overdose of Vildiabate M 500 Tablet 15 can cause nausea, vomiting, abdominal pain, diarrhoea, flatulence and dizziness. If an overdose happens, seek medical attention immediately and follow the instructions accordingly.

If you miss a dose of Vildiabate M 500 Tablet 15, take it as soon as you remember. However, avoid repeating the dose.